
Oppenheimer lifts its PT on Kenexa ( KNXA ) to $33 after a positive meeting with management. The firm believes Kenexa's cloud HR software is gaining share, thanks in
software names have sold off: CSOD +1.2% . CTCT -1% . N -0.2% . Others are faring better: SABA +5.7% . CRM +3% . KNXA +2.4% . Bernstein thinks Oracle's modest premium, perhaps due to a limited number of potential buyers, " puts a cap
Taleo deal is lifting the shares of several cloud business software names that haven't yet been bought out. CSOD +8.2% . KNXA +6.4% . SABA +4.8% . CTCT +1.1% . The deal might also affect the IPO valuation of Workday . Post your comment!
of $0.95-$1.07, compared with a consensus of $331.1M and $1.07. Top-line guidance is boosted by the acquisition of cloud e-learning software firm OutStart. KNXA -10.9% AH. TLEO -2.1% . ( PR ) Post your comment!
Kenexa ( KNXA ): Q4 EPS of $0.27 beats by $0.01 . Revenue of $79.6M (+24.2% Y/Y) beats by $2.3M . Shares -10.9% AH. ( PR ) Post your comment!
Greetings and welcome to the Kenexa Corp. Fourth Quarter 2011 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
acquisitions of vertical solutions such as the deals discussed above. SaaS specialists including NetSuite N, Taleo TLEO, Kenexa KNXA and privately held Workday could all be in play as the on-premise software giants seek to build out broad cloud portfolios
software stocks, as SAP/SuccessFactors helps stoke a frenzy of buying ( I , II , III ). A few more names surging on the news: KNXA +13.7% . SABA +13.9% CSOD +9.5% . CTCT +5.3% . ARBA +11.4% . TNGO +5.1% . Some traditional business software
We are placing Kenexa KNXA under review as we transfer coverage to a new analyst.
A activity , and SAP's big purchase will likely stoke investor hopes for further deal activity. Some other cloud software names that could be on the move on Monday: KNXA , TLEO , CSOD , TNGO , N , LPSN , CTCT , SREV . Post your comment!